Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes (Q46764321)
Jump to navigation
Jump to search
scientific article published on 9 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes |
scientific article published on 9 February 2008 |
Statements
1 reference
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes (English)
1 reference
Wei Meng
1 reference
Bruce A Ellsworth
1 reference
Alexandra A Nirschl
1 reference
Peggy J McCann
1 reference
Manorama Patel
1 reference
Ravindar N Girotra
1 reference
Gang Wu
1 reference
Philip M Sher
1 reference
Eamonn P Morrison
1 reference
Scott A Biller
1 reference
Robert Zahler
1 reference
Prashant P Deshpande
1 reference
Annie Pullockaran
1 reference
Deborah L Hagan
1 reference
Nathan Morgan
1 reference
Joseph R Taylor
1 reference
Mary T Obermeier
1 reference
William G Humphreys
1 reference
Ashish Khanna
1 reference
Lorell Discenza
1 reference
James G Robertson
1 reference
Aiying Wang
1 reference
Songping Han
1 reference
John R Wetterau
1 reference
Evan B Janovitz
1 reference
Oliver P Flint
1 reference
Jean M Whaley
1 reference
William N Washburn
1 reference
9 February 2008
1 reference
1 reference
51
1 reference
1145-1149
1 reference
5
1 reference
Identifiers
1 reference
1 reference